MKI67 and breast cancer: The observed interrelations of IL-1β expression with Ki-67 as a reliable marker for proliferation in BC suggests a putative approach for multivariate immunohistochemical profiles integrating, which improved the prognostic and presumably also the predictive accuracy by combining several markers [24].